CClinicalTrials.gg
CompletedNCT02013401MIBLSUpdated Oct 18, 2018

Transmission of Mother-Infant Stress Communication

An observational study in Stress, sponsored by University of Massachusetts, Boston. Completed at 2 sites in United States. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-18.

Sponsored by University of Massachusetts, Boston · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
56
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

The central aim of this study is to assess mother-infant communication via behavioral, physiological, and affective indices under conditions where distal stressors may not be directly detectable by the infant.

Read the detailed description

This investigation examines a distal maternal stressor on the quality of interaction in mother-infant dyadic communication. Assessments include behavioral, physiological, and affective indices under conditions where distal stressors may not be directly detectable by the infant. The present research examines mother-infant interactions to test the hypothesis of whether maternal stress may be transduced to their infants via multiple pathways. The secondary aim is to explore effective emotion regulation strategies for the mother as potential buffers to stress and additionally reducing early life stress effects on the infant's regulatory development.

While the emotion regulation literature posits that reappraisal may be associated with decreased in physiological and psychological stress, this type of regulation strategy may be ineffective when interfacing with discrimination. The regulation strategy needs to be titrated to the stressor in order to be effective. These findings will have notable social, clinical, and psychological significance,

02

Conditions studied

  • Stress

Keywords

  • mother-infant dyadic regulation
  • stress
  • psychophysiology
  • emotion regulation
03

In context

Lead sponsor

University of Massachusetts, Boston is the lead sponsor of 22 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Community sample of women (ages 18-40) with infants ages 4-9 months

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • No presence of heart murmur or wear a pacemaker
  • No medication for hypertensive or cardiovascular disease
  • Not using beta blockers
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
56 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Salivary Cortisol

    Salivary cortisol is a measure that indicates hypothalamus-pituitary-adrenal axis activity. The study obtains 4 assessments with 20 minutes between each assessment. Participants chew on a cotton role for 2-minutes which is placed in a cortisol salivette tube (Sarstedt)

    Time frame: One lab appointment for approximately 80 minutes.

Secondary outcomes

  1. Salivary Amylase

    Salivary amylase is an indicator of sympathetic nervous system activity. The same salivary salivette is used to later extract the amylase.

    Time frame: One lab appointment for approximately 80 minutes.

Other outcomes

  1. Mother-infant observations

    At four assessment occasions during the one time visit, the mother and infant are observed for a free 2-minute period. Observations include global affect, and (present or not) vocalizations, infant fussiness, and motor activity.

    Time frame: One lab appointment for approximately 80 minutes.

07

Study locations

2 sites
  • University of Mass. Boston
    Boston, Massachusetts 02125, United States
  • University of Massachusetts, Boston, Child Development Unit
    Boston, Massachusetts 02125, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02013401
Lead sponsor
University of Massachusetts, Boston
Responsible party
Sponsor
First posted
Dec 17, 2013
Start date
Oct 2013
Primary completion
Jul 14, 2016
Completion
Jul 14, 2016
Last update
Oct 18, 2018

Study contacts

Kymberlee O'Brien, PhD
principal investigator · Postdoctoral Research Fellow
Celia L Moore, PhD
study director · Director of DSRC and Horizon Center
Edward Tronick, PhD
study director · Director Child Development Unit

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion